Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The discovery of fibroblast growth factor 23 (FGF23) as the causal factor in the pathogenesis of rare forms of hypophosphatemic rickets is rapidly reshaping our understanding of disordered mineral metabolism in chronic kidney disease (CKD). Excessive production of FGF23 by osteocytes is an appropriate compensation to help maintain normal phosphorus metabolism in these patients. Beginning in early CKD, progressive increases in levels of FGF23 enhance phosphaturia on a per-nephron basis and inhibit calcitriol production, thereby contributing centrally to the predominant phosphorus phenotype of predialysis kidney disease: normal serum phosphate, increased fractional excretion of phosphate, and calcitriol deficiency. A proliferation of studies linking phosphorus and now FGF23 excess to adverse renal and cardiovascular outcomes in patients with CKD is setting the stage for novel clinical trials that could ultimately bring FGF23 testing into the clinic. Ten burning questions must be addressed to galvanize FGF23 research further in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis
Shimada, T., Hasegawa, H., Yamazaki, Y., Muto, T., Hino, R., Takeuchi, Y., Fujita, T., Nakahara, K., Fukumoto, S., & Yamashita, T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301264 · Cited by 1,883
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationAutosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Levin, A., Bakris, G. L., Molitch, M., Smulders, M., Tian, J., Williams, L. A., & Andress, D. L. (2007) · Kidney International · doi:10.1038/sj.ki.5002009 · Cited by 1,513
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
The parathyroid is a target organ for FGF23 in rats
Ben-Dov, I. Z., Galitzer, H., Lavi-Moshayoff, V., Goetz, R., Kuro-o, M., Mohammadi, M., Sirkis, R., Naveh-Many, T., & Silver, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32409 · Cited by 951
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Self-citationFibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R., Larsson, T., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 914
Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., & Curhan, G. (2005) · Circulation · doi:10.1161/circulationaha.105.553198 · Cited by 885
Dhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Self-citationActivated Injectable Vitamin D and Hemodialysis Survival: A Historical Cohort Study
Teng, M., Wolf, M., Ofsthun, M. N., Lazarus, J. M., Hernán, M. A., Camargo, C. A., & Thadhani, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070573 · Cited by 782
Self-citationFliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
Larsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
Evidence for alteration of the vitamin D-endocrine system in obese subjects.
Bell, N. H., Epstein, S., Greene, A., Shary, J., Oexmann, M. J., & Shaw, S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111971 · Cited by 685
Fibroblast Growth Factor 23 Is a Counter-Regulatory Phosphaturic Hormone for Vitamin D
Liu, S., Tang, W., Zhou, J., Stubbs, J. R., Luo, Q., Pi, M., & Quarles, L. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111185 · Cited by 642
Sitara, D., Razzaque, M. S., Hesse, M., Yoganathan, S., Taguchi, T., Erben, R. G., J+APw-ppner, H., & Lanske, B. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.09.007 · Cited by 542
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
Benet-Pagès, A., Orlik, P., Strom, T. M., & Lorenz-Depiereux, B. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi034 · Cited by 507
Larsson, T., Marsell, R., Schipani, E., Ohlsson, C., Ljunggren, Ö., Tenenhouse, H. S., Jüppner, H., & Jonsson, K. B. (2004) · Endocrinology · doi:10.1210/en.2003-1768 · Cited by 499
Severely Reduced Production of Klotho in Human Chronic Renal Failure Kidney
Koh, N., Fujimori, T., Nishiguchi, S., Tamori, A., Shiomi, S., Nakatani, T., Sugimura, K., Kishimoto, T., Kinoshita, S., Kuroki, T., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4226 · Cited by 494
Tsujikawa, H., Kurotaki, Y., Fujimori, T., Fukuda, K., & Nabeshima, Y.-I. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0048 · Cited by 491
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Ichikawa, S., Imel, E. A., Kreiter, M. L., Yu, X., Mackenzie, D. S., Sorenson, A. H., Goetz, R., Mohammadi, M., White, K. E., & Econs, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31330 · Cited by 482
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog
Slatopolsky, E., Caglar, S., Pennell, J. P., Taggart, D. D., Canterbury, J. M., Reiss, E., & Bricker, N. S. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106517 · Cited by 481
Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo
Saito, H., Maeda, A., Ohtomo, S.-I., Hirata, M., Kusano, K., Kato, S., Ogata, E., Segawa, H., Miyamoto, K.-I., & Fukushima, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408903200 · Cited by 471
Endocrine functions of bone in mineral metabolism regulation
Quarles, L. D. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36479 · Cited by 459
Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and Women
Burnett, S.-A. M., Gunawardene, S. C., Bringhurst, F. R., Jüppner, H., Lee, H., & Finkelstein, J. S. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060507 · Cited by 455
Shimada, T. (2002) · Endocrinology · doi:10.1210/en.143.8.3179 · Cited by 446
Shimada, T., Urakawa, I., Yamazaki, Y., Hasegawa, H., Hino, R., Yoneya, T., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.102 · Cited by 429
Perwad, F., Azam, N., Zhang, M. Y. H., Yamashita, T., Tenenhouse, H. S., & Portale, A. A. (2005) · Endocrinology · doi:10.1210/en.2005-0777 · Cited by 425
Dietary Phosphorus Regulates Serum Fibroblast Growth Factor-23 Concentrations in Healthy Men
Antoniucci, D. M., Yamashita, T., & Portale, A. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0021 · Cited by 421
Saito, H., Kusano, K., Kinosaki, M., Ito, H., Hirata, M., Segawa, H., Miyamoto, K.-I., & Fukushima, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207872200 · Cited by 414
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
Mirza, M. A. I., Larsson, A., Lind, L., & Larsson, T. E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.001 · Cited by 386
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Oliveira, R. B., Cancela, A. L. E., Graciolli, F. G., Dos Reis, L. M., Draibe, S. A., Cuppari, L., Carvalho, A. B., Jorgetti, V., Canziani, M. E., & Moysés, R. M. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05420709 · Cited by 357
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, O. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 354
Portale, A. A., Booth, B. E., Halloran, B. P., & Morris, R. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111365 · Cited by 353
Jean, G., Terrat, J.-C., Vanel, T., Hurot, J.-M., Lorriaux, C., Mayor, B., & Chazot, C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp191 · Cited by 351
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization
Quarles, L. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00016.2003 · Cited by 333
Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C. (2004) · Endocrinology · doi:10.1210/en.2004-0233 · Cited by 329
Shigematsu, T., Kazama, J. J., Yamashita, T., Fukumoto, S., Hosoya, T., Gejyo, F., & Fukagawa, M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.029 · Cited by 326
Perwad, F., Zhang, M. Y. H., Tenenhouse, H. S., & Portale, A. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00463.2006 · Cited by 300
Preservation of Function in Experimental Renal Disease by Dietary Restriction of Phosphate
Ibels, L. S., Alfrey, A. C., Haut, L., & Huffer, W. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801192980302 · Cited by 296
Bai, X.-Y., Miao, D., Goltzman, D., & Karaplis, A. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210490200 · Cited by 276
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
Pereira, R. C., Jűppner, H., Azucena-Serrano, C. E., Yadin, O., Salusky, I. B., & Wesseling-Perry, K. (2009) · Bone · doi:10.1016/j.bone.2009.08.008 · Cited by 272
Wang, H., Yoshiko, Y., Yamamoto, R., Minamizaki, T., Kozai, K., Tanne, K., Aubin, J. E., & Maeda, N. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080220 · Cited by 263
Levin, A. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16025.x · Cited by 261
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Schouten, B. J., Hunt, P. J., Livesey, J. H., Frampton, C. M., & Soule, S. G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2396 · Cited by 235
Martinez, I., Saracho, R., Montenegro, J., & Llach, F. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90330-9 · Cited by 234
Shimada, T., Urakawa, I., Isakova, T., Yamazaki, Y., Epstein, M., Wesseling-Perry, K., Wolf, M., Salusky, I. B., & Jüppner, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1603 · Cited by 229
Self-citationRelationship between circulating FGF23 and total body atherosclerosis in the community
Mirza, M. A. I., Hansen, T., Johansson, L., Ahlström, H., Larsson, A., Lind, L., & Larsson, T. E. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp205 · Cited by 223
Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23
Yu, X., Ibrahimi, O. A., Goetz, R., Zhang, F., Davis, S. I., Garringer, H. J., Linhardt, R. J., Ornitz, D. M., Mohammadi, M., & White, K. E. (2005) · Endocrinology · doi:10.1210/en.2005-0670 · Cited by 213
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Bhan, I., Shah, A., Holmes, J., Isakova, T., Gutierrez, O., Burnett, S.-A., Jüppner, H., & Wolf, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001788 · Cited by 194
Self-citationStubbs, J. R., Idiculla, A., Slusser, J., Menard, R., & Quarles, L. D. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009040451 · Cited by 192
Evenepoel, P., Naesens, M., Claes, K., Kuypers, D., & Vanrenterghem, Y. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01753.x · Cited by 173
FGF-23 Is Elevated by Chronic Hyperphosphatemia
Gupta, A., Winer, K., Econs, M. J., Marx, S. J., & Collins, M. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0724 · Cited by 168
Wesseling‐Perry, K., Pereira, R. C., Wang, H., Elashoff, R. M., Sahney, S., Gales, B., Jüppner, H., & Salusky, I. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0326 · Cited by 164
Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD
Isakova, T., Gutierrez, O., Shah, A., Castaldo, L., Holmes, J., Lee, H., & Wolf, M. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060673 · Cited by 160
Self-citationNorris, K. C., Greene, T., Kopple, J. D., Lea, J. P., Lewis, J., Lipkowitz, M., Miller, P., Richardson, A., Rostand, S. G., Wang, X., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101101 · Cited by 157
Charytan, C., Coburn, J. W., Chonchol, M., Herman, J., Lien, Y.-H. H., Liu, W., Klassen, P., McCary, L. C., & Pichette, V. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.04.013 · Cited by 152
Koiwa, F., Kazama, J. J., Tokumoto, A., Onoda, N., Kato, H., Okada, T., Nii‐Kono, T., Fukagawa, M., & Shigematsu, T. (2005) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2005.00293.x · Cited by 147
Nagano, N., Miyata, S., Abe, M., Kobayashi, N., Wakita, S., Yamashita, T., & Wada, M. (2006) · Kidney International · doi:10.1038/sj.ki.5000020 · Cited by 143
Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans
Ito, N., Fukumoto, S., Takeuchi, Y., Takeda, S., Suzuki, H., Yamashita, T., & Fujita, T. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0779-3 · Cited by 138
Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man.
Lambert, P. W., Stern, P. H., Avioli, R. C., Brackett, N. C., Turner, R. T., Greene, A. S., Fu, I. Y., & Bell, N. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110501 · Cited by 135
Nishi, H., Nii‐Kono, T., Nakanishi, S., Yamazaki, Y., Yamashita, T., Fukumoto, S., Ikeda, K., Fujimori, A., & Fukagawa, M. (2005) · Nephron Clinical Practice · doi:10.1159/000086347 · Cited by 131
Indirect Regulation of PTH by Estrogens May Require FGF23
Carrillo‐López, N., Román‐García, P., Rebollar, A. R., Martín, J. L. F., Naves‐Díaz, M., & Cannata-Andía, J. B. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121258 · Cited by 115
Strom, T. M., & Jüppner, H. (2008) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e3282fd6e5b · Cited by 106
Bone Formation Regulates Circulating Concentrations of Fibroblast Growth Factor 23
Samadfam, R., Richard, C., Nguyen-Yamamoto, L., Bolivar, I., & Goltzman, D. (2009) · Endocrinology · doi:10.1210/en.2009-0472 · Cited by 106
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
Isakova, T., Gutiérrez, O. M., & Wolf, M. S. (2009) · Kidney International · doi:10.1038/ki.2009.246 · Cited by 103
Self-citationRegulation of fibroblast growth factor-23 in chronic kidney disease
Westerberg, P.-A., Linde, T., Wíkström, B., Ljunggren, Ö., Stridsberg, M., & Larsson, T. E. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm347 · Cited by 103
Corda, S., Mebazaa, A., Gandolfini, M.-P., Fitting, C., Marotte, F., Peynet, J., Charlemagne, D., Cavaillon, J., Payen, D. M., Rappaport, L., et al. (1997) · Circulation Research · doi:10.1161/01.res.81.5.679 · Cited by 90
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
Gutiérrez, O. M., Isakova, T., Andress, D. L., Levin, A., & Wolf, M. S. (2008) · Kidney International · doi:10.1038/ki.2008.4 · Cited by 79
Self-citationVitamin D Deficiency and Associated Factors in Hemodialysis Patients
Jean, G., Charra, B., & Chazot, C. (2008) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.04.003 · Cited by 67
Klotho in chronic kidney disease--What's new?
Kuro‐o, M. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp069 · Cited by 58
Foley, R. N., Wang, C., Ishani, A., & Collins, A. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121411 · Cited by 49
Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men
Burnett‐Bowie, S. M., Mendoza, N., & Leder, B. Z. (2006) · Bone · doi:10.1016/j.bone.2006.10.016 · Cited by 37
Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats
Scheinowitz, M., Kotlyar, A., Zimand, S., Ohad, D. G., Leibovitz, I., Bloom, N., Goldberg, I., Nass, D., Engelberg, S., Savion, N., et al. (1998) · Experimental Physiology · doi:10.1113/expphysiol.1998.sp004140 · Cited by 28
Cited by
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationIsakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Self-citationIsakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Regulation and Function of the FGF23/Klotho Endocrine Pathways
Martin, A., David, V., & Quarles, L. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00002.2011 · Cited by 594
Update on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
Self-citation
Metadata
- Authors
- Wolf, M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2010-09
- Volume
- 21
- Issue
- 9
- Pages
- 1427-1435
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2142343526
- Cited by
- 308
- References
- 80
- FWCI
- 21.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.